Watson C J, Bossenmaier I, Cardinal R, Petryka Z J
Proc Natl Acad Sci U S A. 1974 Feb;71(2):278-82. doi: 10.1073/pnas.71.2.278.
Hematin administered intravenously in a patient with congenital erythropoietic porphyria evidently entered erythrocyte precursors in the bone marrow, producing the well-known negative feedback repression of porphyrin biosynthesis with marked decline of porphyrin concentrations in urine, circulating plasma, and erythrocytes. A delay in the major segment of this effect corresponded roughly with the sum of the average transit times through the maturation compartments of the erythrocyte precursors. This delay was considerably longer than previously observed in the decline of porphyrin precursors after administration of hematin in patients with hepatic porphyria. The effect of hematin was compared with that of packed erythrocyte transfusions given at regular intervals in the same patient over a period of 2.5 years. In general, administration of hematin results in a reduction of porphyrin formation of the same order of magnitude, but of shorter duration, possibly in relation to the relatively small amounts of hematin infused.
给先天性红细胞生成性卟啉病患者静脉注射血红素后,血红素显然进入了骨髓中的红细胞前体,对卟啉生物合成产生了众所周知的负反馈抑制作用,导致尿液、循环血浆和红细胞中的卟啉浓度显著下降。这种效应的主要部分出现延迟,大致与红细胞前体成熟区室的平均转运时间总和相对应。这一延迟比先前在肝性卟啉病患者中注射血红素后卟啉前体下降所观察到的时间长得多。在2.5年的时间里,将同一患者定期输注浓缩红细胞的效果与注射血红素的效果进行了比较。一般来说,注射血红素会使卟啉生成减少到相同的数量级,但持续时间较短,这可能与注入的血红素量相对较少有关。